The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovascular age-related macular degeneration

被引:31
作者
Singh, Amardeep [1 ]
Sorensen, Torben L. [1 ]
机构
[1] Copenhagen Univ Hosp, Dept Ophthalmol, DK-4000 Roskilde, Denmark
关键词
age-related macular degeneration; Charles Bonnet syndrome; geographic atrophy; low vision; visual hallucinations; VISUAL HALLUCINATIONS; DISEASE;
D O I
10.1111/j.1755-3768.2010.02051.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
. Purpose: To investigate the prevalence and clinical characteristics of the Charles Bonnet Syndrome (CBS) in a group of Danish patients with neovascular age-related macular degeneration (AMD) and to study whether CBS is associated with a specific retinal morphology. Methods: Three-hundred consecutive patients with neovascular AMD attending assessment consultations following variable series of ranibizumab therapy were actively asked whether they had symptoms of CBS. If they responded positively, a detailed questionnaire was orally administered to inquire into the details of the symptoms. Detailed optical coherence tomography and autofluorescence was performed. A comparison was made between retinal morphology of a randomly selected equal number of patients without CBS to patients with CBS. Results: Twenty-five (8.3%) patients of 300 had hallucinations attributable to CBS. The median lesion size measured as total area with increased autofluorescence in the CBS group (median 14.2 mm2) was not significantly different from the non-CBS group (median 16.2 mm2); however, the patients with CBS had significantly larger areas of geographic atrophy (median 2 mm2) compared to patients without CBS (median 0.3 mm2) (p = 0.002). Conclusion: CBS is not uncommon in an unselected population with neovascular AMD, and symptoms of CBS may be associated with larger areas of geographic atrophy.
引用
收藏
页码:476 / 480
页数:5
相关论文
共 50 条
  • [41] Guidance for the treatment of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Richard, Gisbert
    Augustin, Albert
    Aylward, William G.
    Bandello, Francesco
    Corcostegui, Borja
    Cunha-Vaz, Jose
    Gaudric, Alain
    Leys, Anita
    Schlingemann, Rainier O.
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 486 - 494
  • [42] Association of neovascular age-related macular degeneration with migraine
    Kuang, Tung-Mei
    Xirasagar, Sudha
    Kao, Yi-Wei
    Ho, Jau-Der
    Lin, Herng-Ching
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [43] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [44] Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age-Related Macular Degeneration
    Basile, Anthony S.
    Hutmacher, Matt
    Nickens, Dana
    Nielsen, Jace
    Kowalski, Ken
    Whitfield, Lloyd
    Masayo, Oishi
    Nakane, Masami
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (08) : 1186 - 1199
  • [45] The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
    Musial-Kopiejka, Magdalena
    Polanowska, Katarzyna
    Dobrowolski, Dariusz
    Krysik, Katarzyna
    Wylegala, Edward
    Grabarek, Beniamin Oskar
    Lyssek-Boron, Anita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [46] CORRELATION BETWEEN NEOVASCULAR LESION TYPE AND CLINICAL CHARACTERISTICS OF NONNEOVASCULAR FELLOW EYES IN PATIENTS WITH UNILATERAL, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Marsiglia, Marcela
    Boddu, Sucharita
    Chen, Christine Y.
    Jung, Jesse J.
    Mrejen, Sarah
    Gallego-Pinazo, Roberto
    Freund, K. Bailey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (05): : 966 - 974
  • [47] An update on the pharmacotherapy of neovascular age-related macular degeneration
    Freund, K. Bailey
    Mrejen, Sarah
    Gallego-Pinazo, Roberto
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (08) : 1017 - 1028
  • [48] The nature and frequency of neovascular age-related macular degeneration
    Iranmanesh, R.
    Eandi, C. M.
    Peiretti, E.
    Klais, C. M.
    Garuti, S.
    Goldberg, D. E.
    Slakter, J. S.
    Yannuzzi, L. A.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (01) : 75 - 83
  • [49] Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
    Blazaki, Styliani
    Blavakis, Emmanouil
    Chlouverakis, Gregory
    Bontzos, Georgios
    Chatziralli, Irini
    Smoustopoulos, Georgios
    Dimitriou, Eleni
    Stavrakakis, Anastasios
    Kabanarou, Stamatina
    Xirou, Tina
    Vavvas, Demetrios G.
    Tsilimbaris, Miltiadis K.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (12) : 3425 - 3436
  • [50] Vitreomacular Adhesion and Neovascular Age-Related Macular Degeneration
    Simpson, Andrew R. H.
    Petrarca, Robert
    Jackson, Timothy L.
    SURVEY OF OPHTHALMOLOGY, 2012, 57 (06) : 498 - 509